Showing results (11-20 of 108) with videos related to
Sort By:
Pageof 11
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology AssessmentDevin Incerti, Howard Thom, Gianluca Baio, et al.Nature Reviews. Drug Discovery|October 2, 2012
In search of preclinical robustnessIan S Peers, Peter R Ceuppens, Chris HarbronBioinformatics (Oxford, England)|July 12, 2007
RefPlus: an R package extending the RMA AlgorithmChris Harbron, Kai-Ming Chang, Marie C SouthPharmacoeconomics - Open|February 22, 2018
Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm InfantsAhva Shahabi, Desi Peneva, Devin Incerti, et al.Pharmaceutical Statistics|July 17, 2022
Left truncation in linked data: A practical guide to understanding left truncation and applying it using SAS and RYanling Jin, Thanh G N Ton, Devin Incerti, et al.Statistics in Medicine|June 16, 2024
A multi-arm multi-stage platform design that allows preplanned addition of arms while still controlling the family-wise errorPeter Greenstreet, Thomas Jaki, Alun Bedding, et al.Health Economics|February 22, 2020
An empirical investigation of time-varying cost-effectiveness across the product life cycleWarren Stevens, Devin Incerti, Desi Peneva, et al.Pharmaceutical Statistics|March 27, 2015
Experimental designs for detecting synergy and antagonism between two drugs in a pre-clinical studyMatthew Sperrin, Helene Thygesen, Ting-Li Su, et al.Statistics in Medicine|July 16, 2016
An adaptive design for updating the threshold value of a continuous biomarkerAmy V Spencer, Chris Harbron, Adrian Mander, et al.Pharmaceutical Statistics|August 3, 2013
Investigation of the robustness of two models for assessing synergy in pre-clinical drug combination studiesAnne Whitehead, Ting-Li Su, Helene Thygesen, et al.Pageof 11